Genomically Driven Precision Medicine to Improve Outcomes in Anaplastic Thyroid Cancer

Thyroid cancer is an endocrine malignancy with an incidence rate that has been increasing steadily over the past 30 years. While well-differentiated subtypes have a favorable prognosis when treated with surgical resection and radioiodine, undifferentiated subtypes, such as anaplastic thyroid cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Nicole, Black, Morgan, Patel, Krupal, Yoo, John, Mymryk, Joe S., Barrett, John W., Nichols, Anthony C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170827/
https://www.ncbi.nlm.nih.gov/pubmed/25276134
http://dx.doi.org/10.1155/2014/936285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170827/
https://www.ncbi.nlm.nih.gov/pubmed/25276134
http://dx.doi.org/10.1155/2014/936285

Ejemplares similares